Predict your next investment

Asset/Investment Management
FINANCIAL | Asset/Financial Management

See what CB Insights has to offer

Investments

6

About QuestCap

QuestCap is an investment company that focuses on equity, debt, and other securities of publicly traded and private companies.

QuestCap Headquarter Location

65 Queen Street West Suite 800

Toronto, Ontario, M5H 2M5,

Canada

416-861-5888

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest QuestCap News

Day One Launch of Collection Sites COVID-19 Testing Site at Town of East Hampton Model of Success

Jan 7, 2021

Day One Launch of Collection Sites COVID-19 Testing Site at Town of East Hampton Model of Success TORONTO, Jan. 07, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (formerly “QuestCap Inc.”) (NEO:MEDV; OTC:COPRF; FRA:34C1) is pleased to announce the opening of a new collection site at the Town of East Hampton’s Town Hall Campus was highly successful. This site saw substantial demand for important COVID-19 testing services on the first day of operation and will serve as a replicable model for future site launches across the United States. Meanginful COVID-19 Testing Services Provide On Opening Day at East Hampton https://www.globenewswire.com/NewsRoom/AttachmentNg/306433b0-7251-461c-a8bd-c7d7c8f1bee2 https://www.globenewswire.com/NewsRoom/AttachmentNg/e864cf68-7a48-42f8-8a51-458f848f59eb Figure 1 & 2: Images of Line-ups at East Hampton’s Town Hall Campus With individual sites currently achieving strong sales with 7-day rolling average of 95 tests per day and average test price exceeding US$95 per test, this one site is expected to add to Medivolve’s top-line revenue immediately.As a reminder, effective yesterday the Company commence trading of its common shares under its new name “Medivolve Inc.” and new ticker “MEDV” on the NEO.About the East Hampton Collection Site OpeningLocal media has also recognized the value of Collection Sites COVID-19 testing centres, covering the launch of the site with an article ( view article ). Please note this site be a standard walk-up testing site. With a strong location and a town population of over 20,000, this testing site is expected to generate strong sales over the period of operation.“By partnering with the local municipality, we were able to successfully launch a Collection Site in a short time period and see strong sales on the first day,” says Mr. Tim Shelburn, President of Collection Sites. “We are excited see the success of this approach and will strive to replicate it. We commend the municipality for their forward thinking approach to COVID-19 testing for their constituents.”The pop-up labs will be managed by Las Vegas based company Collection Sites, LLC and powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. Appointments and payments will be handled through an online portal  www.testbeforeyougo.com .The key to flattening the curve is to increase testing.The testing centers will offer convenient access to rapid antibody and antigen (pending availability) tests – which take 8-10 minutes to administer and provide results within 24 hours. The sites also offer regular RT-PCR. All tests can be administered with insurance coverage options. The tests results can be communicated via text or email and can be accompanied with a certificate of good health via a HIPAA-compliant smartphone application.For more information about the pop-up lab, the available sites and services visit  www.testbeforeyougo.com .About Medivolve Inc. Medivolve Inc. (NEO:MEDV; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, Medivolve offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.Medivolve has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.Medivolve’s primary focus is the sale of COVID-19 IgG/IgM antibody tests authorized by FDA under an EUA for use by authorized laboratories. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal  www.testbeforeyougo.com . Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.For additional information, please contact:Doug Sommerville, CEO Doug.Sommerville@questcapinc.com

QuestCap Investments

6 Investments

QuestCap has made 6 investments. Their latest investment was in Spectral Analytics as part of their Corporate Minority on August 8, 2020.

CBI Logo

QuestCap Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/4/2020

Corporate Minority

Spectral Analytics

Yes

1

7/9/2020

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

6/16/2020

Secondary Market

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2020

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

4/9/2020

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/4/2020

7/9/2020

6/16/2020

4/16/2020

4/9/2020

Round

Corporate Minority

Corporate Minority

Secondary Market

Corporate Minority

Unattributed

Company

Spectral Analytics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

QuestCap Acquisitions

1 Acquisition

QuestCap acquired 1 company. Their latest acquisition was Amino Therapeutics on April 03, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/3/2020

$991

Acquired

5

Date

4/3/2020

Investment Stage

Companies

Valuation

$991

Total Funding

Note

Acquired

Sources

5

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.